[Form 4] UiPath, Inc. Insider Trading Activity

Rhea-AI Filing Summary

UiPath, Inc. (PATH) reporting person Brad Brubaker, GC & Chief Legal Officer, disclosed a sale of 66,665 shares of Class A common stock on 10/06/2025 under a pre-established Rule 10b5-1 selling plan. The reported sale prices ranged from $15.0000 to $15.0050, and after the transaction Mr. Brubaker beneficially owned 690,519 shares directly.

The filing confirms the sale was executed pursuant to a qualified 10b5-1 plan and the filer offered to provide transaction-level price details to the Commission staff or security holders upon request. No derivative transactions or other changes in beneficial ownership were reported on this form.

Positive

• Sale executed under a qualified Rule 10b5-1 plan, which provides structured compliance for insider transactions
• Full post-transaction ownership disclosed: 690,519 Class A shares remaining, ensuring transparency

Negative

• Insider reduced holdings by 66,665 shares, which may modestly lower insider stake concentration
• Sale price near $15.00 could be perceived as a signal of the insider's liquidity needs rather than confidence

Insights

Corporate Governance Analyst

Insider used a pre‑arranged 10b5‑1 plan to sell a portion of holdings on 10/06/2025.

The sale of 66,665 Class A shares at prices between $15.0000 and $15.0050 reduces direct ownership to 690,519 shares and was disclosed on a Section 16 Form 4. Use of a Rule 10b5‑1 plan indicates the transactions were pre‑planned and intended to provide an affirmative defense to insider trading claims.

Risks include routine insider liquidity rather than company performance signals; monitor subsequent Form 4 filings or any amendments for additional sales or changes to the plan within the next several months.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brubaker Brad

(Last) (First) (Middle)

C/O UIPATH, INC., ONE VANDERBILT AVENUE

60TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UiPath, Inc. [ PATH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	GC & Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/06/2025		S		66,665(1)	D	$15.0001(2)	690,519	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.

2. The range of prices for the transactions reported was from $15.0000 to $15.0050. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

Remarks:

	/s/ Brad Brubaker	10/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did UiPath insider Brad Brubaker report on Form 4 (PATH)?

He reported a sale of 66,665 Class A shares on 10/06/2025, executed under a qualified Rule 10b5-1 plan, with prices between $15.0000 and $15.0050.

How many UiPath (PATH) shares does Brad Brubaker own after the sale?

The Form 4 states he beneficially owns 690,519 Class A shares following the reported transaction.

Was the sale by the PATH reporting person part of a 10b5-1 plan?

Yes. The filing explicitly says the shares were sold in compliance with a qualified selling plan adopted pursuant to Rule 10b5-1.

What price range was reported for the PATH share sales?

The reported range of transaction prices was from $15.0000 to $15.0050.

Did the Form 4 report any option exercises or derivative transactions for PATH?

No. Table II (derivatives) shows no reported derivative transactions in this filing.